Hippocratic AI, a global leader in generative AI healthcare solutions, announced that it has more than doubled its team over the past year and is strengthening its executive leadership by bringing on industry veterans across several key functions. These strategic hires are intended to help the company meet growing demand from healthcare providers, payors, government agencies, and life sciences organizations while advancing its mission to create healthcare abundance through scalable, patient-facing generative AI. The expanded team also enhances Hippocratic AI’s ability to support its growing partner network with the operational expertise, clinical knowledge, and responsiveness required for successful deployment and long-term impact. Earlier this month, Hippocratic AI completed a Series C funding round and has surpassed 115 million patient interactions.
Health Technology Insights: Itaca Unveils AI Tool for Auto Clinical Notes in Telehealth
Munjal Shah, CEO and Co-founder of Hippocratic AI, stated that the company is seeing significant momentum as health systems, payors, and life sciences organizations increasingly adopt safe generative AI agents to close critical gaps in care and improve access to healthcare. He said the addition of experienced executives with deep knowledge in healthcare, commercial strategy, and operations strengthens the company’s ability to scale responsibly while maintaining high standards for safety and efficacy in AI-driven healthcare solutions.
The new executive team includes Anan Kashyap as Chief Financial Officer. Kashyap has extensive experience in finance and operations, having held senior roles at Xero, Ethos, Poshmark, GrubHub, and Kayak, and has successfully guided companies through IPOs, acquisitions, and global expansion. Craig Ikens joins as Chief Commercial Officer for Blues and Regional Plans, bringing more than 25 years of healthcare strategy and business development experience, including leadership roles at HCSC, Livongo, and Teladoc Health, focusing on payor-facing initiatives. Dr. Herprit Mahal MD, FACP, has been appointed Associate Chief Medical Officer. Dr. Mahal is a practicing hospital physician at Kaiser Permanente and previously served as medical director at Suki. She has over twenty years of clinical experience and a strong commitment to using technology to improve access to evidence-based care.
Health Technology Insights: Daiichi Sankyo Begins Trial for STING Agonist ADC DS-3610
Peter Casasanto joins as Chief Commercial Officer for Pharma, bringing more than 20 years of experience in commercial leadership at the intersection of AI and life sciences. He previously led Tempus AI’s AI Apps Business Unit and has held executive positions at SOPHiA Genetics and Deep 6 AI. Rahul Agarwal, MBBS, MBA, MHSA, is now Chief Customer Officer. Agarwal is a physician and healthcare leader with over 20 years of experience in clinical operations, customer success, and AI implementation. He previously led Sales and Client Success at TeleTracking Technologies and held senior positions at Qventus and Catholic Health Initiatives, now known as CommonSpirit Health.
Sejal Rajagopalan has joined as Chief People Officer. With more than twenty years of experience building HR functions at growth-stage companies including SmithRx, C3, and ServiceMax, she has a strong record of scaling people operations while maintaining organizational culture. Dr. Shubhra Jain, MD, MBA, joins as Chief Business Officer. Dr. Jain is a physician, product leader, and healthcare investor with prior roles at Tarsadia Investments, Cota Capital, and a previous healthcare AI startup. She will lead commercial strategy and partnerships across the healthcare ecosystem at Hippocratic AI.
The expansion of Hippocratic AI’s team and leadership ensures the company remains well-positioned to deliver enterprise-grade solutions that prioritize clinical safety, build patient trust, and generate measurable outcomes. This growth supports the company’s vision of using generative AI to expand access to high-quality healthcare and to address unmet needs across multiple healthcare sectors.
Health Technology Insights: Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
